The intent of the FY19 CPMRP TRA is to support translational research that will accelerate the movement of evidence-based ideas in chronic pain management research into clinical applications, including healthcare products, technologies, and/or clinical practice guidelines.

TRA applications should

credit:

explain how the proposed work will inform the development, refinement, and/or revision of existing standards of care, recommendations, or guidelines for managing chronic pain.

Studies seeking to develop novel pharmacological therapies or non-pharmacological approaches that consist entirely of a clinical trial do not meet the intent of the award mechanism.

Clinical trials evaluating opioid-based therapeutic interventions are not allowed.